Prevalence And Genotypic Characterisation of Occult Hepatitis B Infection in Blood Donors at Gulu Regional Blood Bank, Northern Uganda.
No Thumbnail Available
Date
2026
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Gulu University
Abstract
Occult hepatitis B infection is defined as presence of HBV DNA in blood or liver cells of individuals who test negative for hepatitis B surface antigen (HBsAg). HBV remains one of the most prevalent viral infections spread through blood transfusion in Northern Uganda. This study aimed to ascertain the prevalence of OBI in blood donors from northern Uganda to provide evidenced data to improve blood safety program in the region and consequently reduce HBV infection through blood transfusion. A cross-sectional study was used to determine the prevalence of OBI among individuals who donate blood at Gulu regional blood bank. A total of 1,067 donated blood sampled using systematic random sampling technique were screened for HBsAg and HBV nucleic acid (DNA). Samples that tested HBsAg negative and HBV DNA positive were further tested for anti-HBc as marker for seropositive OBI, and OBI DNA sequences were genotyped by phylogenetic analysis using MEGAv.12 software to ascertain HBV genotype. Data were entered in MS Excel software and analyzed using IBM SPSS Software V.20. In a total of 1,067 blood samples collected from voluntary blood donors, 35.2% (n=376) and 64.8% (n=691) were females and males respectively. Male and female blood donors had statistically significant HBV infection rates of 2.8% and 0.5%, respectively (X2 (1, N=1067) = 6.962, p=0.008). While the frequency of HBV infection in new and repeat blood donors was 1.8% and 1.5% respectively; however, there was no significant difference (X2 (2, N=1067) = 4.190, p= 0.123). The prevalence of OBI was 0.9% (10/1067), hepatitis B recombinant genotype D/E was (83.3%) and genotype D was (16.7%) respectively. Sensitivity and specificity for HBsAg was 71.4% and 99.9% respectively. There was significant difference between use of HBsAg and HBV DNA NAT for screening of hepatitis B infection among blood donors in northern Uganda (McNemar test X2, P=.012). The study provides evidence of OBI infection and its circulating genotypes in northern Uganda. HBsAg test showed low analytical sensitivity compared to NAT test. Therefore, use of HBsAg alone for screening of blood donation is not adequate to eliminate the risk of transmission of HBV through blood transfusion. Introducing parallel testing with both HBsAg and HBV DNA could reduce on the risk of OBI transmission and better confirm HBV infection in blood donors in Northern Uganda. The study further recommends studies using larger number of HBV sequences to comprehensively explore the OBI strains in the region.